Cargando…
Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia
Clonal hematopoiesis (CH) is associated with adverse outcomes in patients with non-Hodgkin lymphoma (NHL) and multiple myeloma undergoing autologous stem cell transplantation. Still, its implications for patients with indolent NHL have not been well studied. We report the prevalence of CH in patient...
Autores principales: | Tahri, Sabrin, Mouhieddine, Tarek H., Redd, Robert, Lampe, Luisa, Nilsson, Katarina I., El-Khoury, Habib, Su, Nang Kham, Nassar, Amin H., Adib, Elio, Bindra, Govind, Abou Alaiwi, Sarah, Trippa, Lorenzo, Steensma, David P., Castillo, Jorge J., Treon, Steven P., Ghobrial, Irene M., Sperling, Adam S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Hematology
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9006277/ https://www.ncbi.nlm.nih.gov/pubmed/34847227 http://dx.doi.org/10.1182/bloodadvances.2021004926 |
Ejemplares similares
-
Genomic landscape of Waldenström's macroglobulinemia
por: Treon, Steven P., et al.
Publicado: (2019) -
Bruton tyrosine kinase inhibitors in the management of Waldenström macroglobulinemia
por: Castillo, Jorge J., et al.
Publicado: (2023) -
The importance of the genomic landscape in Waldenström's Macroglobulinemia for targeted therapeutical interventions
por: Sacco, Antonio, et al.
Publicado: (2017) -
Evaluation of clonal hematopoiesis in pediatric ADA-SCID gene therapy participants
por: White, Shanna L., et al.
Publicado: (2022) -
Profiling of circulating exosomal miRNAs in patients with Waldenström Macroglobulinemia
por: Bouyssou, Juliette M., et al.
Publicado: (2018)